MURPHY ALLEN: Open Payments
NPI 1770544983 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 52 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $718 · 2025 $914
Food & beverage: $914
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $261 |
| Amgen Inc. | 4 | $88 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Tris Pharma Inc | 2 | $47 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $46 |
| PFIZER INC. | 3 | $45 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
Products named: VRAYLAR, QULIPTA, OTEZLA, BREZTRI, Qelbree, Dyanavel XR, NURTEC ODT, UBRELVY.
Industry payments across NV — which companies pay providers there.
